Garvan's medical research will transform healthcare. We explore the full spectrum of disease so that everyone can live longer and healthier lives.
Translating breakthrough research into precision medicine.
Our greatest strength lies in the exceptional talent and dedication of our people, who are at the forefront of medical research and innovation.
A hub for breaking news, event updates, podcasts and essential resources on human health and disease.
Our mission is to harness the information encoded in our genome to better diagnose, treat, predict and prevent disease.
Our research relies on the generous support of people like you. Show your support for breakthrough medical research today
We’re harnessing genetic information to revolutionise healthcare by translating our groundbreaking research into better diagnostics and treatments.
Our researchers ask the tough questions and work collaboratively to create a healthier future for everyone.
Garvan Institute has a number of research centres which bring together scientists in core areas.
Garvan Institute has a breadth of research platforms offering research expertise, coupled with services.
Providing world-leading scientific services and facilities to researchers.
Garvan Institute's research publications
The studies currently underway at Garvan.
Garvan researchers are researching a full spectrum of diseases so that everyone can live longer and healthier lives.
The future health of Australians depends on generous people and brave research. Read how our research is making an impact in the community.
Garvan's genomic technologies empower family to make crucial healthcare decisions.
A life-changing diagnosis through genome sequencing.
How genetics and immunology diagnosed Michael’s life-long mystery disease.
A Garvan-led research team called CIRCA gives new hope to patients like Oscar, who are living with critical, rare immune conditions.
Pancreatic cancer patients are contributing to a world-first global study helping to advancing medical research.
Thanks to the Garvan-led research program CIRCA, patients living with critical, rare immune conditions are receiving life-saving treatment.